Nitric oxide production by human proximal tubular cells: a novel immunomodulatory mechanism?

[1]  G. Hawksworth,et al.  Isolation and characterisation of human proximal tubular cells derived from kidney cortical segments , 1995, Human & experimental toxicology.

[2]  V. Cattell,et al.  Nitric oxide: role in the physiology and pathology of the glomerulus. , 1993, Experimental nephrology.

[3]  M. Daha,et al.  CsA, FK506, corticosteroids and rapamycin inhibit TNFα production by cultured PTEC , 1993 .

[4]  A. Macleod,et al.  Induction of nitric oxide synthase in human mesangial cells. , 1993, Biochemical and biophysical research communications.

[5]  M. Marletta,et al.  Nitric oxide synthase structure and mechanism. , 1993, The Journal of biological chemistry.

[6]  J. R. Lancaster,et al.  Nitric oxide--a new endogenous immunomodulator. , 1993, Transplantation.

[7]  S. Milstien,et al.  Availability of tetrahydrobiopterin is not a factor in the inability to detect nitric oxide production by human macrophages. , 1993, Biochemical and biophysical research communications.

[8]  D. Kohan,et al.  Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells. , 1993, The Journal of clinical investigation.

[9]  S H Snyder,et al.  Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  V. Kelley,et al.  The antigen presentation function of renal tubular epithelial cells. , 1993, Experimental nephrology.

[11]  A. Sher,et al.  The microbicidal activity of interferon‐γ‐treated macrophages against Trypanosoma cruzi involves an L‐arginine‐dependent, nitrogen oxide‐mediated mechanism inhibitable by interleukin‐10 and transforming growth factor‐β , 1992, European journal of immunology.

[12]  T. Eisenstein,et al.  Immunosuppression induced by nitric oxide and its inhibition by interleukin‐4 , 1992, European journal of immunology.

[13]  P. Neuhaus,et al.  Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. , 1992, The Journal of clinical investigation.

[14]  S. Moncada.  Nitric oxide gas: mediator, modulator, and pathophysiologic entity. , 1992, The Journal of laboratory and clinical medicine.

[15]  E. Ruoslahti,et al.  Transforming growth factor-beta in disease: the dark side of tissue repair. , 1992, The Journal of clinical investigation.

[16]  A. Nussler,et al.  Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin , 1992, The Journal of experimental medicine.

[17]  A. Sher,et al.  IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. , 1992, Journal of immunology.

[18]  Terry D. Lee,et al.  Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. , 1992, Science.

[19]  J. Floege,et al.  Platelet-derived growth factor: a potentially important cytokine in glomerular disease. , 1992, Kidney international.

[20]  S. Moncada,et al.  The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids , 1992, British journal of pharmacology.

[21]  J. Pfeilschifter.  Platelet-derived growth factor inhibits cytokine induction of nitric oxide synthase in rat renal mesangial cells. , 1991, European journal of pharmacology.

[22]  H. Cook,et al.  Glomerular nitrite synthesis in in situ immune complex glomerulonephritis in the rat. , 1991, The American journal of pathology.

[23]  D. Morton,et al.  Interleukin 4 Alone and with γ-Interferon or α-Tumor Necrosis Factor Inhibits Cell Growth and Modulates Cell Surface Antigens on Human Renal Cell Carcinomas , 1991 .

[24]  M. Hung,et al.  Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro. , 1991, Journal of immunology.

[25]  M. Marletta,et al.  Synthesis and action of nitric oxide in rat glomerular mesangial cells. , 1991, The American journal of physiology.

[26]  N. Ostojić,et al.  Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice. , 1991, Biochemical and biophysical research communications.

[27]  T. Billiar,et al.  Nitric oxide synthesis in the in vivo allograft response: a possible regulatory mechanism. , 1991, Surgery.

[28]  J. Hevel,et al.  Tissue injury caused by deposition of immune complexes is L-arginine dependent. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G. Schreiner.  The role of the macrophage in glomerular injury. , 1991, Seminars in nephrology.

[30]  T. Mosmann,et al.  Functional diversity of T lymphocytes due to secretion of different cytokine patterns , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  G. Hawksworth,et al.  Maintenance of glucose uptake in suspensions and cultures of human renal proximal tubular cells. , 1990, Toxicology letters.

[32]  S. Moncada,et al.  Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. , 1990, Journal of immunology.

[33]  A. Hassid,et al.  Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators. , 1989, The American journal of physiology.

[34]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[35]  J. Sedor,et al.  Cytokines, mesangial cell activation and glomerular injury. , 1993, Kidney international. Supplement.

[36]  H. Kolb,et al.  Nitric oxide: a pathogenetic factor in autoimmunity. , 1992, Immunology today.

[37]  R. Busse,et al.  Interleukin 1 beta and tumour necrosis factor alpha induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. , 1992, European journal of biochemistry.

[38]  V. Cattell,et al.  Glomeruli synthesize nitrite in active Heymann nephritis; the source is infiltrating macrophages. , 1991, Kidney international.

[39]  H. Kolb,et al.  Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitor. , 1991, Life sciences.

[40]  S. Snyder,et al.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. , 1990, Proceedings of the National Academy of Sciences of the United States of America.